Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 16, 2021 07:30 ET | Source: OpGen, Inc.

OpGen Subsidiary Ares Genetics Announces Publication of Study Introducing Best Practice Techniques for AI-powered Prediction of Antibiotic Susceptibility Testing by Next-Generation Sequencing

Study highlights best practice techniques for accurate antimicrobial resistance prediction from whole-genome sequencing data Publication supports harmonization of the development of good machine...
February 09, 2021 08:30 ET | Source: OpGen, Inc.

OpGen, Inc. Announces $25 Million Registered Direct Offering Priced At-the-Market Under NASDAQ Rules

GAITHERSBURG, Md., Feb. 09, 2021 (GLOBE NEWSWIRE) -- OpGen, Inc. (Nasdaq: OPGN, “OpGen”), a precision medicine company harnessing the power of molecular diagnostics and bioinformatics to help combat...
January 13, 2021 07:30 ET | Source: OpGen, Inc.

OpGen Announces Preliminary Unaudited Revenue for Fiscal 2020 and Provides Business Update

Preliminary total pro-forma combined revenue for 2020 was approximately $5.2 millionMaintained strong balance sheet with $13.3 million cash as of December 31, 2020 and total capital raised in 2020 of...
January 05, 2021 07:30 ET | Source: OpGen, Inc.

OpGen Subsidiary Curetis and Annar Enter into Unyvero Distribution Partnership for Colombia

Exclusive distribution agreement for initial term of three yearsAnnar commits to minimum purchase of 10 Unyvero systems during initial term Annar to seek regulatory clearance for Unyvero products in...
December 17, 2020 08:00 ET | Source: OpGen, Inc.

Results from 1,400 Patient Sample Multicenter Study Published: Unyvero LRT BAL Panel Provides Accurate Detection in Bronchoalveolar Lavage Fluid, Allowing Enhanced Diagnosis of Lower Respiratory Tract Infections

Early diagnosis and proper choice of antimicrobials are crucial for successful management of pneumoniaStudy demonstrates Unyvero LRT BAL provides accurate detection of common agents of bacterial...
December 09, 2020 07:30 ET | Source: OpGen, Inc.

OpGen Announces Planned Leadership Transition at Next Generation Sequencing and Bioinformatics Subsidiary Ares Genetics

Dr. Arne Materna to join Ares Genetics as new Managing Director and CEO to lead Ares into next phase of its growth Dr. Andreas Posch, while stepping down as Managing Director and CEO to pursue new...
December 01, 2020 07:30 ET | Source: OpGen, Inc.

OpGen Group Company Ares Genetics Advances ares-genetics.cloud Platform, Presents Update at Scientific Conferences, Expects Granting of Key Patent

Extended collaboration with leading global generics company Sandoz for optimal antibiotic drug positioning by predictive antibiotic susceptibility testing Presenting study on combining...
November 24, 2020 08:00 ET | Source: OpGen, Inc.

OpGen, Inc. Announces $10 Million Private Placement Priced at the Market

GAITHERSBURG, Md., Nov. 24, 2020 (GLOBE NEWSWIRE) -- OpGen, Inc. (Nasdaq: OPGN, “OpGen”), a precision medicine company harnessing the power of molecular diagnostics and bioinformatics to help combat...
November 12, 2020 07:30 ET | Source: OpGen, Inc.

OpGen Group Company Ares Genetics Commercially Launches NGS-based Antibiotic Resistance Testing Service for Native Specimens and Receives Bulk Order from Public Health Agency

Early access program launched for the next generation of the ARESupa Universal Pathogenome Assay based on targeted next-generation sequencing (NGS) of native specimens First commercial orders...
November 11, 2020 16:05 ET | Source: OpGen, Inc.

OpGen Reports Third Quarter 2020 Financial Results and Provides Business Update

OpGen takes strategic steps to expand the Unyvero platform and product pipeline, to focus on the pending Acuitas AMR Gene Panel (isolates) FDA clearance and expects to invest significantly in...